Volume 16, Number 7—July 2010
Dispatch
Vaccine-associated Paralytic Poliomyelitis in Immunodeficient Children, Iran, 1995–2008
Table 2
Patient no. | Underlying immunodeficiency | Leukocytes, cells/μL | ALC, cells/μL | CD3,† cells/μL | CD4,† cells/μL | CD8,† cells/μL | CD19,† cells/μL | IgG,‡ mg/dL | IgM,‡ mg/dL | IgA,‡ mg/dL |
---|---|---|---|---|---|---|---|---|---|---|
1 | Undefined hypogammaglobulinemia | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2 | MHC class II deficiency | 6,300 | 3,642 | 1,216 | 608 | 607 | 1,460 | 200 | <10 | <10 |
3 | SCID | 1,700 | 731 | 138 | 96 | 32 | 10 | 45 | <10 | <10 |
4 | XLA | 6,500 | 3,375 | 2,700 | 1,404 | 1,290 | 35 | 556 | <10 | <10 |
5 | SCID | 6,800 | 2,589 | 336 | 184 | 185 | 160 | <10 | <10 | <10 |
6 | XLA | 8,500 | 4,000 | 2,760 | 1,920 | 835 | 40 | 20 | 58 | 25 |
*ALC, absolute lymphocyte count; Ig, immunoglobulin; NA, not available; MHC, major histocompatibility complex; SCID, severe combined immunodeficiency; XLA, X-linked agammaglobulinemia.
†Reference ranges for lymphocyte subpopulations: CD3, 1,900–5,900; CD4, 1,400–4,300; CD8, 500–1,700; CD19, 610–2,600 cells/μL.
‡Reference ranges for immunoglobulins: IgG, 661 ± 219; IgM, 54 ± 23; IgA, 37 ± 18.
Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.